Pharmaceutical Science Update

December 6, 2017

Delayed FDA Guidance Clarifies Drug Product Identifier Policy

Drug distributors and pharmacists finally have draft guidance from the Food and Drug Administration (FDA) on how to handle products that are already in the supply chain that do not have product identifiers (82 Fed. Reg. 56,033).

Related Stories